SCHEMBL21392822

SCHEMBL21392822

O=C(CCl)N(Cc1ccccc1O)c1ccc2c(c1)OCO2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.66
MEN1 O00255 6/20 0.66
RAB9A P51151 6/20 0.66
NPC1 O15118 5/20 0.66
PAX8 Q06710 4/20 0.66
GPX4 P36969 1/20 0.66
ALDH1A1 P00352 6/20 0.52
HTT P42858 4/20 0.52
JAK2 O60674 2/20 0.52
LMNA P02545 1/20 0.52
MAPT P10636 1/20 0.52
FNIP1 Q8TF40 1/20 0.50
FEM1B Q9UK73 1/20 0.50
INSR P06213 1/20 0.44
IGF1R P08069 1/20 0.44
SRC P12931 1/20 0.44
TRPM8 Q7Z2W7 2/20 0.42
POLB P06746 3/20 0.42
TSHR P16473 1/20 0.42
MITF O75030 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21401721 0.88 KMT2A (0.66) KMT2AMEN1RAB9ANPC1PAX8
SCHEMBL21392985 0.87 MEN1 (0.64) KMT2AMEN1RAB9ANPC1PAX8
SCHEMBL21392964 0.85 NPC1 (0.62) KMT2AMEN1RAB9ANPC1PAX8
SCHEMBL21401863 0.85 KMT2A (0.62) KMT2AMEN1RAB9ANPC1PAX8
SCHEMBL21392987 0.84 KMT2A (0.61) KMT2AMEN1RAB9ANPC1PAX8
SCHEMBL21393049 0.84 KMT2A (0.61) KMT2AMEN1RAB9ANPC1PAX8
SCHEMBL21401880 0.84 KMT2A (0.61) KMT2AMEN1RAB9ANPC1PAX8
SCHEMBL21401891 0.81 RAB9A (0.58) KMT2AMEN1RAB9ANPC1PAX8
SCHEMBL21392821 0.80 MEN1 (0.74) KMT2AMEN1RAB9ANPC1PAX8
SCHEMBL15428399 0.80 KMT2A (1.00) KMT2AMEN1RAB9ANPC1PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
WO-2019183600-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-09-26 WO disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 KMT2A 3168/4885MEN1 4319/4885RAB9A 223/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 KMT2A 3168/4885MEN1 4319/4885RAB9A 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.